Cargando…
Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease
BACKGROUND: Mesenchymal stromal cell (MSC)-based therapy is a promising strategy for preventing the progression of chronic kidney disease (CKD), with the potential to induce tissue regeneration. In search of the best cellular source we compared, in the rat model of adriamycin (ADR) nephropathy, the...
Autores principales: | Rota, Cinzia, Morigi, Marina, Cerullo, Domenico, Introna, Martino, Colpani, Ornella, Corna, Daniela, Capelli, Chiara, Rabelink, Ton J., Leuning, Danielle G., Rottoli, Daniela, Benigni, Ariela, Zoja, Carlamaria, Remuzzi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092807/ https://www.ncbi.nlm.nih.gov/pubmed/30107860 http://dx.doi.org/10.1186/s13287-018-0960-8 |
Ejemplares similares
-
Protective Effects of Human Nonrenal and Renal Stromal Cells and Their Conditioned Media in a Rat Model of Chronic Kidney Disease
por: Imberti, Barbara, et al.
Publicado: (2020) -
Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function
por: Perico, Luca, et al.
Publicado: (2017) -
Add-On Cyclic Angiotensin-(1-7) with Cyclophosphamide Arrests Progressive Kidney Disease in Rats with ANCA Associated Glomerulonephritis
por: Cerullo, Domenico, et al.
Publicado: (2022) -
Sirtuin 3 Deficiency Aggravates Kidney Disease in Response to High-Fat Diet through Lipotoxicity-Induced Mitochondrial Damage
por: Locatelli, Monica, et al.
Publicado: (2022) -
Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor
por: Zanchi, Cristina, et al.
Publicado: (2013)